Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$4.02 - $5.39 $349 - $468
87 Added 0.53%
16,564 $70,000
Q2 2023

Aug 11, 2023

SELL
$4.19 - $6.16 $6,280 - $9,233
-1,499 Reduced 8.34%
16,477 $90,000
Q2 2022

Aug 15, 2022

SELL
$3.28 - $6.42 $58,961 - $115,405
-17,976 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$5.16 - $7.14 $92,756 - $128,348
17,976 New
17,976 $111,000
Q1 2022

May 20, 2022

SELL
$5.16 - $7.14 $25,118 - $34,757
-4,868 Reduced 21.31%
17,976 $112,000
Q4 2021

Feb 16, 2022

SELL
$6.37 - $8.18 $1,254 - $1,611
-197 Reduced 0.85%
22,844 $161,000
Q3 2021

Nov 12, 2021

SELL
$6.98 - $8.47 $12,913 - $15,669
-1,850 Reduced 7.43%
23,041 $161,000
Q2 2021

Aug 12, 2021

SELL
$5.44 - $8.4 $2,616 - $4,040
-481 Reduced 1.9%
24,891 $207,000
Q1 2021

May 03, 2021

SELL
$3.91 - $6.99 $9,071 - $16,216
-2,320 Reduced 8.38%
25,372 $139,000
Q4 2020

Feb 12, 2021

BUY
$3.0 - $4.5 $3,126 - $4,689
1,042 Added 3.91%
27,692 $119,000
Q2 2020

Aug 10, 2020

BUY
$2.12 - $3.14 $56,498 - $83,681
26,650 New
26,650 $83,000
Q2 2019

Aug 14, 2019

SELL
$1.93 - $4.59 $52,395 - $124,609
-27,148 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$2.77 - $4.38 $914 - $1,445
330 Added 1.23%
27,148 $117,000
Q4 2018

Feb 14, 2019

BUY
$3.03 - $5.0 $1,330 - $2,195
439 Added 1.66%
26,818 $85,000
Q3 2018

Nov 14, 2018

SELL
$5.0 - $6.65 $17,415 - $23,161
-3,483 Reduced 11.66%
26,379 $138,000
Q2 2018

Aug 14, 2018

BUY
$4.2 - $5.95 $123,383 - $174,793
29,377 Added 6057.11%
29,862 $160,000
Q1 2018

May 15, 2018

SELL
$3.3 - $5.15 $5,313 - $8,291
-1,610 Reduced 76.85%
485 $2,000
Q4 2017

Feb 08, 2018

SELL
$3.08 - $3.8 $1,456 - $1,797
-473 Reduced 18.42%
2,095 $7,000
Q3 2017

Nov 14, 2017

BUY
$2.7 - $3.75 $6,933 - $9,630
2,568
2,568 $10,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.